Article Published: Pharma Company Influence On Study Results

My article on pharmaceutical company influence on study results was published in the American Association For Justice Spring 2012 Products Liability Newsletter. The article is entitled “Critical Analysis of Scientific Data: Introduction to Funder Bias” and is available online here. Stay tuned for more!

Read full story | Comments { 0 }

House To Begin Debate On Malpractice Reform Legislation

WASHINGTON — House Republicans are taking another stab at changing health care policy. The House Wednesday is slated to begin debate on a GOP proposal to limit medical malpractice costs. House to begin debate on malpractice reform legislation | NOLA.com.

Read full story | Comments { 0 }

Generic Drugs Prove Resistant to Damage Claims – NYTimes.com

Debbie Schork, a deli worker at a supermarket in Indiana, had to have her hand amputated after an emergency room nurse injected her with an anti-nausea drug, causing gangrene. She sued the manufacturer named in the hospital’s records for failing to warn about the risks of injecting it. Her case was quietly thrown out of [...]

Read full story | Comments { 0 }

NJ Judge To Roche “No New Trial For You”

In a March 14 decision, Judge Carol E. Higbee of the Atlantic County Superior Court upheld a $2 million verdict against Accutane maker Roche for failing to warn about the risk of inflammatory bowel disease.

Read full story | Comments { 0 }
The Bark’s Best Of The Week March 2, 2012

The Bark’s Best Of The Week March 2, 2012

Top Five News For The Week Ending March 2, 2012 Enterprise pressured not to rent vehicles under recall. You can rent a car today that is under a safety recall and not know it. FDA Releases Industry Guidance Asking Drugmakers To Explain Delays In Adverse Event Reporting. Drugmakers unable to report timely post-market adverse events during [...]

Read full story | Comments { 0 }
Major NY Hospital Caught Bilking Medicare

Major NY Hospital Caught Bilking Medicare

Beth Israel Hospital will pay the federal government $13 million for fraudulently inflating bills to Medicare, in a settlement that provides a rare glimpse into financial decision-making among hospital executives. Federal prosecutors alleged that Beth Israel abused a system of “outlier payments” that lets hospitals bill Medicare — the healthcare system for the elderly — [...]

Read full story | Comments { 0 }
Medicare Fraud Is Out Of Control

Medicare Fraud Is Out Of Control

Times are tough. Everyone is feeling the pinch of a bad economy. Unfortunately financial pressures lead some people to do the wrong thing. Now, more than ever, healthcare providers are being caught billing Medicare for services never performed or received. Medicare is health insurance provided by the federal government for people 65 or older and [...]

Read full story | Comments { 0 }
The Bark’s Best Of The Week February 25, 2012

The Bark’s Best Of The Week February 25, 2012

Can Obama’s New Consumer Privacy Bill Keep Your Data Safe? Today, the Obama administration is to unveil a new Consumer Privacy Bill of Rights, which it hopes to roll out in order to protect people’s privacy online. The question is, can it work? Chemical Used For Stripping Bathtubs Kills 13. Financial connections between drug recommendations [...]

Read full story | Comments { 0 }
The Bark’s Best Of The Week February 17, 2012

The Bark’s Best Of The Week February 17, 2012

My top five stories return this week with a little bit of the same ‘ole. Johnson & Johnson is having the worst two-and-a-half year run in the history of the 126 year old company in my opinion. The EPA FINALLY got around to releasing their long anticipating dioxin safety assessment. Without further ado, here are [...]

Read full story | Comments { 0 }
Congressman Waxman Pushing NIH, FDA On Unpublished Clinical Trial Data

Congressman Waxman Pushing NIH, FDA On Unpublished Clinical Trial Data

On February 14, 2012 Rep. Henry A. Waxman, Rep. Edward J. Markey, and Rep. Diana DeGette wrote to NIH Director Francis Collins and FDA Commissioner Margaret Hamburg expressing concern over a recent report documenting the underreporting of results of clinical drug trials. The report, published in the British Medical Journal, found that researchers and pharmaceutical companies routinely [...]

Read full story | Comments { 0 }